Chromadex's total assets for Q4 2024 were $66.19M, an increase of 17.11% from the previous quarter. CDXC total liabilities were $20.10M for the fiscal quarter, a -9.28% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.